Micreos

OverviewSuggest Edit

Micreos is a company that develops antibacterial products aiming to replace antibiotics. It leverages technology that is based on the use of phages and can be applied in various areas, including human health, food safety, animal health, and agriculture.
TypePrivate
Founded2005
HQDen Haag, NL
Websitemicreos.com

Latest Updates

Employees (est.) (Nov 2021)122
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Micreos

Skyler Stein

Skyler Stein

President Micreos Health North America
Josephine Offerhaus

Josephine Offerhaus

Director Strategy Gladskin
Bert de Vegt

Bert de Vegt

Managing Director, Micreos Food Safety
Mark Offerhaus

Mark Offerhaus

CEO
Michael Riedlin

Michael Riedlin

COO
Johan Frieling

Johan Frieling

Chief Medical Officer
Show more

Micreos Office Locations

Micreos has offices in Den Haag, Bilthoven and Wageningen
Den Haag, NL (HQ)
Bankaplein 2
Bilthoven, NL
Antonie van Leeuwenhoeklaan 9
Wageningen, NL
Nieuwe Kanaal 7p
Show all (3)

Micreos Financials and Metrics

Summary Metrics

Founding Date

2005

Micreos total Funding

$12 m

Micreos latest funding size

$12 m

Time since last funding

6 years ago
Micreos's latest funding round in February 2016 was reported to be $12 m. In total, Micreos has raised $12 m
Show all financial metrics

Micreos Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Micreos Online and Social Media Presence

Embed Graph

Micreos News and Updates

Micreos appoints Matt Regan as CEO of its Pharmaceutical business

THE HAGUE, Netherlands, Oct. 14, 2021 /PRNewswire/ -- Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland. Following rapid growth, Micreos is preparing to spin-out its Pharmaceutical business into a...

Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis

THE HAGUE, Netherlands, Sept. 22, 2020 /PRNewswire/ -- Dutch biotech company Micreos Human Health has enrolled the first patients in a Phase I/IIa, randomized, double-blind, placebo-controlled, parallel treated dose-ranging study to assess the safety and efficacy of XZ.700 in patients...

Micreos Frequently Asked Questions

  • When was Micreos founded?

    Micreos was founded in 2005.

  • Who are Micreos key executives?

    Micreos's key executives are Skyler Stein, Josephine Offerhaus and Bert de Vegt.

  • How many employees does Micreos have?

    Micreos has 122 employees.

  • Who are Micreos competitors?

    Competitors of Micreos include Mcneil, The Searle Company and Serum Institute of India.

  • Where is Micreos headquarters?

    Micreos headquarters is located at Bankaplein 2, Den Haag.

  • Where are Micreos offices?

    Micreos has offices in Den Haag, Bilthoven and Wageningen.

  • How many offices does Micreos have?

    Micreos has 3 offices.